Brainstorm Cell Therapeutics Inc. BCLI
0.83 USD 0.00 (+0.05%)
Nov 3, 2026, 1:52 PM EST
0.826 Day range 0.85
0.46 52-week range 1.69
- YTD
- +50.20%
- 1 year
- +27.09%
Analyst view
Consensus: buy
Buy
Price target (mean) 23.45 +2738.6% upside
Now 0.8261
- Target (low)
- 10.00
- Target (mean)
- 23.45
- Target (high)
- 36.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 1
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.27 | -0.27 – -0.27 | -1.50 | +82.0% | 0 | 0.0% | 1 |
| Current year | -2.10 | -2.10 – -2.10 | -7.62 | +72.4% | 0 | 0.0% | 1 |
| Next year | -1.59 | -1.65 – -1.52 | -2.10 | +24.5% | 0 | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 11, 2024 | Maxim Group | Upgrade | Hold | Buy |
| Sep 28, 2023 | Maxim Group | Downgrade | Buy | Hold |
| Mar 31, 2023 | Maxim Group | Maintained | — | Buy |
| Feb 5, 2021 | Maxim Group | Upgrade | Hold | Buy |
| May 15, 2018 | HC Wainwright & Co. | Initiated | — | Buy |
| Aug 17, 2017 | Maxim Group | Maintained | — | Buy |